Abstract | BACKGROUND: METHODS: In a randomized study, 45 Indian patients (age above 13 years) with vitiligo involving more than 5% body surface area were randomly allocated to receive either NBUVB or P-NBUVB treatment. Both groups received NBUVB exposure thrice weekly, with a total of 60 sessions. The extent of repigmentation achieved was calculated on the basis of Vitiligo Area Severity Index (VASI) scoring. RESULTS: Forty patients were available for analysis at the end of the study. The extent of repigmentation in the P-NBUVB group was statistically significantly greater in face and neck (P = 0.006, t-test) and hands (P = 0.007, t-test) in comparison with the NBUVB group (t-test). Percentage reduction in VASI scores was statistically significantly greater in the P-NBUVB group (29.2% vs. 21.7%, P = 0.043, t-test). The response to P-NBUVB therapy started earlier than the response to NBUVB. After excluding sunlight as a confounding factor, treatment response was also significantly better in the P-NBUVB group (P = 0.005). CONCLUSION: Addition of psoralen increased the extent of repigmentation due to NBUVB therapy in vitiligo. Further studies are required to determine the long-term efficacy and safety of P-NBUVB.
|
Authors | Shivani Bansal, Bijaylaxmi Sahoo, Vijay Garg |
Journal | Photodermatology, photoimmunology & photomedicine
(Photodermatol Photoimmunol Photomed)
Vol. 29
Issue 6
Pg. 311-7
(Dec 2013)
ISSN: 1600-0781 [Electronic] England |
PMID | 24118425
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Photosensitizing Agents
- Ficusin
|
Topics |
- Adolescent
- Adult
- Aged
- Female
- Ficusin
(administration & dosage)
- Humans
- Male
- Middle Aged
- Photochemotherapy
- Photosensitizing Agents
(administration & dosage)
- Skin Pigmentation
(drug effects, radiation effects)
- Ultraviolet Therapy
- Vitiligo
(drug therapy, metabolism, pathology)
|